Insulin Pump Therapy. Continuous Subcutaneous Insulin Infusion

Insulin Pump Therapy. Continuous Subcutaneous Insulin InfusionInsulin pump therapy known as continuous subcutaneous insulin infusion or CSII is an option to deliver insulin for someone affected by sugar diabetes. There are two main options to administer insulin in diabetes management, namely multiple daily insulin injections using syringes and vials, or pen injectors; and continuous subcutaneous insulin infusion, known as insulin pump therapy.


What is insulin pump? Basically it is a medical device that deliver insulin automatically according to preset program through permanently placed needle. Some of the newest insulin pumps combined glucometer and insulin pumping. Real-time interstitial glucose readings are displayed on the pump screen, and alarm would warn user when the glucose levels appeared to be decreasing too fast or become too high above the 240 mg/dl.

Insulin pump therapy allows people with sugar diabetes to manage their diabetes intensively by using a method that is pharmacologically superior to traditional multiple daily insulin injections. Any person with sugar diabetes who uses insulin is a potential candidate for an insulin pump. Although the pumps are more expensive than insulin pens, long-term sugar diabetes management would certainly be simplified.

Using insulin pump in continuous subcutaneous insulin infusion should reduce not only the risk of short-term diabetes complications such as diabetic ketoacidosis and hyperglycemia but also long-term diabetes complications such as microvascular and macrovascular disease.

Insulin pump therapy means intensive diabetes management. Intensive diabetes management propagates very tight blood glucose control. By maintaining very tight blood glucose control person with Type 1 diabetes or Type 2 diabetes can significantly delay or even prevent numerous diabetes complications.

Continuous subcutaneous insulin infusion therapy is designed to mimic normal pancreatic beta-cell function by physiologically delivering both basal and bolus insulin to person with Type 1 diabetes and Type 2 diabetes. Although continuous subcutaneous insulin infusion (CSII) is beyond doubt the most sophisticated and precise insulin-delivery method currently available, people who initiate insulin pump therapy must become solidly committed to intensive diabetes self-management. Blood glucose level must be checked 6 to 8 times per day. People with diabetes must understand insulin pharmacokinetics, carbohydrate counting, and some exercise physiology. Because a pump is a mechanical device that may, of course, malfunction, person must be very adept at correcting unexplained hyperglycemia using knowledge from multiple daily injections with syringe or pen-injector.

Obviously people committed to insulin pump therapy are more self-sufficient and confident than people on traditional diabetes management. It is proven many times over that people control their sugar diabetes condition with much greater success using insulin pump therapy than any other therapy for diabetes management.

Share This: